El informe
Análisis profundos sobre financiación de empresas, estrategias de crecimiento e insights de mercado de los negocios más innovadores del mundo
190 informes y contando
Crystalys Therapeutics raises $205M Series B at $900M valuation
Crystalys Therapeutics raises $205M in Series B at $900M valuation. Developing novel therapeutics for neurodegenerative diseases...
Crystalys Therapeutics Raises $205M in Series A
Crystalys Therapeutics, a Biotech company based in San Diego, CA, has raised $205M in Series A at a $800M valuation led by Novo Holdings, SR One, Catalys Pacific.
Crystalys Therapeutics Raises $205M Series A to Transform Biotech
Crystalys Therapeutics has secured $205M Series A in funding to accelerate growth and innovation in the biotech sector. Clinical-stage biopharmaceutical company developing next-generation oral URAT1 inhibitor dotinurad for the treatment of ...
Arnatar Therapeutics raises $52M Series A
Arnatar Therapeutics raises $52M in Series A. Developing therapeutics for autoimmune and inflammatory diseases...
Denali Therapeutics raises $217M Series C at $5B valuation
Denali Therapeutics raises $217M in Series C at $5B valuation. Neurodegeneration therapeutics...
Strand Therapeutics raises $153M Series B
Strand Therapeutics raises $153M in Series B. mRNA-based therapeutics developer with novel cancer treatment platform...
Seres Therapeutics raises $113M Series E at $450M valuation
Seres Therapeutics raises $113M in Series E at $450M valuation. Microbiome therapeutic platform...
Expedition Therapeutics raises $165M Series B at $850M valuation
Expedition Therapeutics raises $165M in Series B at $850M valuation. Developing novel therapeutics for cardiometabolic diseases...
Kailera Therapeutics raises $400M Series A at $1.5B valuation
Kailera Therapeutics raises $400M in Series A at $1.5B valuation. Developing obesity therapeutics with acquired pipeline...
Mostrando 9 informes • Página 1 • Categoría: all
Mantente a la vanguardia del mercado
Recibe insights semanales en tu bandeja de entrada. Sin spam, solo inteligencia.